SwePub
Sök i LIBRIS databas

  Extended search

(WFRF:(Pantoni L)) hsvcat:3
 

Search: (WFRF:(Pantoni L)) hsvcat:3 > Vascular cognitive ...

Vascular cognitive impairment

van der Flier, W. M. (author)
Skoog, Ingmar, 1954 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi,Centrum för åldrande och hälsa (AgeCap),Institute of Neuroscience and Physiology,Centre for Ageing and Health (Agecap)
Schneider, J. A. (author)
show more...
Pantoni, L. (author)
Mok, V. (author)
Chen, C. L. H. (author)
Scheltens, P. (author)
show less...
 (creator_code:org_t)
2018-02-15
2018
English.
In: Nature Reviews Disease Primers. - : Springer Science and Business Media LLC. - 2056-676X. ; 4
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The term vascular cognitive impairment (VCI) was introduced around the start of the new millennium and refers to the contribution of vascular pathology to any severity of cognitive impairment, ranging from subjective cognitive decline and mild cognitive impairment to dementia. Although vascular pathology is common in elderly individuals with cognitive decline, pure vascular dementia (that is, dementia caused solely by vascular pathology) is uncommon. Indeed, most patients with vascular dementia also have other types of pathology, the most common of which is Alzheimer disease (specifically, the diffuse accumulation of amyloid-beta plaques and neurofibrillary tangles composed of tau). At present, the main treatment for VCI is prevention by treating vascular diseases and other risk factors for VCI, such as hypertension and diabetes mellitus. Despite the current paucity of disease-modifying pharmacological treatments, we foresee that eventually, we might be able to target specific brain diseases to prevent cognitive decline and dementia.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Keyword

quality-of-life
small vessel disease
white-matter hyperintensities
transient ischemic attack
cerebral amyloid angiopathy
randomized
controlled-trial
association/american stroke association
health-care
professionals
placebo-controlled trial
temporal-lobe atrophy
General & Internal Medicine
ui hc
1992
neurology
v42
p473
khann g
1984
neurology
v34
p939
iences
v62
p1002
ockholm
sweden
v5
p130

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view